Coronary artery bypass grafting for single-vessel disease resulted in no perioperative mortality and a 10-year cumulative survival of 93%.
Cohort (n=114)
Does conventional single-vessel CABG provide safe and effective long-term outcomes in patients with single-vessel CAD?
Conventional single-vessel CABG is a safe procedure that provides excellent 10-year survival, symptom relief, and freedom from repeat revascularization.
Short-term outcome and 10-year clinical outcome were reviewed in 114 consecutive patients after coronary artery bypass grafting (CABG) for single-vessel coronary artery disease (CAD). Gated equilibrium radionuclide cineangiography was performed soon after CABG in all cases, and revealed very good early graft patency rates. There was no perioperative mortality, and very low morbidity. During follow-up there were seven late deaths, two from cardiac disease and five from non-cardiac causes. Cumulative survival at 10 years was 93%. Cumulative freedom from additional cardiac invasive procedures was 96%, 93% and 80% at 1, 5, and 10 years, respectively, and cumulative freedom from angina was 93%, 80% and 73%. Conventional single-vessel CABG thus can be safely performed, with minimal postoperative morbidity and no mortality, providing good long-term relief of angina and circumventing need for additional invasive procedures.
I Shapira (1999) conducted a cohort in Single-vessel coronary artery disease (n=114). Coronary artery bypass grafting (CABG) was evaluated on Cumulative survival at 10 years. Coronary artery bypass grafting for single-vessel disease resulted in no perioperative mortality and a 10-year cumulative survival of 93%.